NXGN
Income statement / Annual
Last year (2023), NextGen Healthcare, Inc.'s total revenue was $653.17 M,
an increase of 9.53% from the previous year.
In 2023, NextGen Healthcare, Inc.'s net income was -$2.65 M.
See NextGen Healthcare, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
03/31/2014 |
| Operating Revenue |
$653.17 M
|
$596.35 M
|
$556.82 M
|
$540.24 M
|
$529.17 M
|
$531.02 M
|
$509.62 M
|
$492.48 M
|
$490.23 M
|
$444.67 M
|
| Cost of Revenue |
$342.01 M |
$295.40 M |
$275.42 M |
$267.44 M |
$246.70 M |
$241.54 M |
$223.13 M |
$225.62 M |
$223.16 M |
$220.16 M |
| Gross Profit |
$311.16 M |
$300.95 M |
$281.40 M |
$272.80 M |
$282.48 M |
$289.48 M |
$286.49 M |
$266.86 M |
$267.06 M |
$224.50 M |
| Gross Profit Ratio |
0.48 |
0.5 |
0.51 |
0.5 |
0.53 |
0.55 |
0.56 |
0.54 |
0.54 |
0.5 |
| Research and Development
Expenses |
$82.30 M
|
$76.66 M
|
$75.50 M
|
$83.30 M
|
$80.99 M
|
$81.26 M
|
$78.34 M
|
$65.66 M
|
$69.24 M
|
$41.52 M
|
| General & Administrative
Expenses |
$213.15 M
|
$202.88 M
|
$176.63 M
|
$159.13 M
|
$156.65 M
|
$184.15 M
|
$156.51 M
|
$148.34 M
|
$151.09 M
|
$133.49 M
|
| Selling & Marketing
Expenses |
$10.27 M
|
$6.78 M
|
$3.90 M
|
$6.04 M
|
$8.23 M
|
$9.07 M
|
$7.11 M
|
$7.89 M
|
$7.08 M
|
$15.72 M
|
| Selling, General &
Administrative Expenses |
$223.42 M
|
$209.66 M
|
$180.53 M
|
$165.17 M
|
$164.88 M
|
$193.23 M
|
$163.62 M
|
$156.23 M
|
$158.17 M
|
$149.21 M
|
| Other Expenses |
$3.67 M |
$3.53 M |
$4.45 M |
$4.14 M |
$4.34 M |
$37,000.00 |
-$262,000.00 |
-$166,000.00 |
-$62,000.00 |
-$356,000.00 |
| Operating Expenses |
$309.39 M |
$289.84 M |
$260.48 M |
$252.61 M |
$250.22 M |
$282.30 M |
$252.40 M |
$227.26 M |
$231.11 M |
$195.54 M |
| Cost And Expenses |
$651.40 M |
$585.25 M |
$535.90 M |
$520.05 M |
$496.91 M |
$523.83 M |
$475.53 M |
$452.88 M |
$454.27 M |
$415.71 M |
| Interest Income |
$3.54 M |
$101,000.00 |
$38,000.00 |
$256,000.00 |
$216,000.00 |
$55,000.00 |
$14,000.00 |
$428,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$6.30 M |
$1.50 M |
$3.52 M |
$1.96 M |
$2.81 M |
$3.32 M |
$3.16 M |
$1.30 M |
$0.00 |
$269,000.00 |
| Depreciation &
Amortization |
$36.69 M
|
$42.32 M
|
$49.21 M
|
$4.14 M
|
$5.47 M
|
$7.81 M
|
$40.43 M
|
$5.37 M
|
$3.69 M
|
$4.81 M
|
| EBITDA |
$48.04 M
|
$53.46 M
|
$70.11 M
|
$25.43 M
|
$37.09 M
|
$2.82 M
|
$58.85 M
|
$7.36 M
|
$35.96 M
|
$23.09 M
|
| EBITDA Ratio |
0.08 |
0.09 |
0.13 |
0.05 |
0.07 |
0.03 |
0.15 |
0.09 |
0.08 |
0.09 |
| Operating Income Ratio
|
0.02
|
0.02
|
0.04
|
0.04
|
0.06
|
0.01
|
0.05
|
0.01
|
0.07
|
0.05
|
| Total Other
Income/Expenses Net |
$8.17 M
|
-$5.94 M
|
-$10.28 M
|
-$14.98 M
|
-$2.33 M
|
-$3.23 M
|
-$3.40 M
|
-$1.04 M
|
-$292,000.00
|
-$87,000.00
|
| Income Before Tax |
$4.30 M |
$5.20 M |
$9.28 M |
$4.26 M |
$29.29 M |
-$410,000.00 |
$23.61 M |
$6.32 M |
$35.66 M |
$23.00 M |
| Income Before Tax Ratio
|
0.01
|
0.01
|
0.02
|
0.01
|
0.06
|
-0
|
0.05
|
0.01
|
0.07
|
0.05
|
| Income Tax Expense |
$6.96 M |
$3.58 M |
-$240,000.00 |
-$3.24 M |
$4.79 M |
-$2.83 M |
$5.37 M |
$663,000.00 |
$8.33 M |
$7.32 M |
| Net Income |
-$2.65 M |
$1.62 M |
$9.52 M |
$7.50 M |
$24.49 M |
$2.42 M |
$18.24 M |
$5.66 M |
$27.33 M |
$15.68 M |
| Net Income Ratio |
-0 |
0 |
0.02 |
0.01 |
0.05 |
0 |
0.04 |
0.01 |
0.06 |
0.04 |
| EPS |
-0.04 |
0.02 |
0.14 |
0.11 |
0.38 |
0.0381 |
0.3 |
0.09 |
0.45 |
0.26 |
| EPS Diluted |
-0.0396 |
0.02 |
0.14 |
0.11 |
0.38 |
0.0381 |
0.29 |
0.09 |
0.45 |
0.26 |
| Weighted Average Shares
Out |
$66.35 M
|
$67.37 M
|
$66.74 M
|
$65.47 M
|
$64.42 M
|
$63.44 M
|
$61.82 M
|
$60.64 M
|
$60.26 M
|
$59.92 M
|
| Weighted Average Shares
Out Diluted |
$67.01 M
|
$67.79 M
|
$66.89 M
|
$65.61 M
|
$64.60 M
|
$63.44 M
|
$62.01 M
|
$61.23 M
|
$60.85 M
|
$60.13 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
